Acute Undifferentiated Leukemia

A rare form of leukemia where the cells don’t show clear markers to classify them as either lymphoid or myeloid. It is typically aggressive.

HSCT is considered early in therapy, particularly when remission is achieved after induction chemotherapy.

Patients benefit from early donor identification and transplant planning due to high relapse risk.